Mammary Gland Evaluation in Juvenile Toxicity Studies: Temporal Developmental Patterns in the Male and Female Harlan Sprague-Dawley Rat

Toxicologic Pathology

Volumn 44, Issue 7, 2016, Pages 1034-1058

  Filgo, Adam J ^a,b   Foley, Julie F ^b   Puvanesarajah, Samantha ^c   Borde, Aditi R ^b   Midkiff, Bentley R ^a,d   Reed, Casey E ^b   Chappell, Vesna A ^b   Alexander, Lydia B ^b   Borde, Pretish R ^b   Troester, Melissa A ^c   Bouknight, Schantel A Hayes ^e   Fenton, Suzanne E ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d IL   (United States)

^e CHARLES RIVER LABORATORIES   (United States)

Author keywords

atlas; developmental exposure; histology; HSD; mammary gland; rat; steroid receptor; whole mount

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANDROGEN RECEPTOR; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; PROGESTERONE; PROGESTERONE RECEPTOR; POLYCHLORINATED DIBENZODIOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; FETUS; FETUS DEVELOPMENT; GESTATIONAL AGE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; JUVENILE; LACTATION; MALE; MAMMARY GLAND; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; TOXICITY TESTING; AGING; ANIMAL; DRUG EFFECTS; EMBRYOLOGY; PREGNANCY; PRENATAL EXPOSURE; UDDER;

AGING; ANIMALS; DIETHYLSTILBESTROL; FEMALE; MALE; MAMMARY GLANDS, ANIMAL; POLYCHLORINATED DIBENZODIOXINS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS;

EID: 84988683904     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623316663864     Document Type: Article

References (73)

1. Abdalkhani A., Sellers R., Gent J., Wulitich H., Childress S., Stein B., Boissy R. E., Wysolmerski J. J., Foley J., (2002). Nipple connective tissue and its development: Insights from the K14-PTHrP mouse. Mech Dev 115, 63-77.
2. ACS (American Cancer Society). (2014). Cancer Facts & Figures 2014. American Cancer Society. Accessed June 17, 2016. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/.
3. Axelstad M., Christiansen S., Boberg J., Scholze M., Jacobsen P. R., Isling L. K., Kortenkamp A., Hass U., (2014). Mixtures of endocrine-disrupting contaminants induce adverse developmental effects in preweaning rats. Reproduction 147, 489-501.
4. Basaria S., (2010). Androgen abuse in athletes: Detection and consequences. J Clin Endocrinol Metab 95, 1533-43.
5. Biegel L. B., Cook J. C., Hurtt M. E., O'Connor J. C., (1998). Effects of 17 beta-estradiol on serum hormone concentrations and estrous cycle in female Crl: CD BR rats: Effects on parental and first generation rats. Toxicol Sci 44, 143-54.
6. Brown N. M., Lamartiniere C. A., (1995). Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ Health Perspect 103, 708-13.
7. Brown N. M., Manzolillo P. A., Zhang J. X., Wang J., Lamartiniere C. A., (1998). Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 19, 1623-29.
8. Cardiff R. D., Wellings S. R., (1999). The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia 4, 105-22.
9. Cardy R. H., (1991). Sexual dimorphism of the normal rat mammary gland. Vet Pathol 28, 139-45.
10. CDC (Center for Disease Control and Prevention). (2014). United States Cancer Statistics: 1999-2011 Incidence and Mortality Web-based Report. Department of Health and Human Services and National Cancer Institute, Atlanta, GA.
11. Cheung C. C., Thornton J. E., Nurani S. D., Clifton D. K., Steiner R. A., (2001). A reassessment of leptin's role in triggering the onset of puberty in the rat and mouse. Neuroendocrinology 74, 12-21.
12. Colon I., Caro D., Bourdony C. J., Rosario O., (2000). Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 108, 895-900.
13. Cotroneo M. S., Wang J. W., Fritz A., Eltoum I. E., Lamartiniere C. A., (2002). Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis 23, 1467-74.
14. Darcy K. M., Wohlhueter A. L., Zangani D., Vaughan M. M., Russell J. A., Masso-Welch P. A., Varela L. M., Shoemaker S. F., Horn E., Lee P. P., Huang R. Y., Ip M. M., (1999). Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells. Eur J Cell Biol 78, 511-23.
15. Davis B., Fenton S. E., (2013). Mammary gland. In Haschek and Rousseaux's Handbook of Toxicologic Pathology (Haschek W. M., Rousseaux C. G., Wallig M. A., eds.), pp. 2665-94. Elsevier Academic Press, New York, NY.
16. Detre S., Saclani Jotti G., Dowsett M., (1995). A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48, 876-78.
17. Dohler K. D., Wuttke W., (1975). Changes with age in levels of serum gonadotropins, prolactin and gonadal steroids in prepubertal male and female rats. Endocrinology 97, 898-907.
18. Durmaz E., Ozmert E. N., Erkekoglu P., Giray B., Derman O., Hincal F., Yurdakök K., (2010). Plasma phthalate levels in pubertal gynecomastia. Pediatrics 125, e122-29. doi: 10.1542/peds.2009-0724.
19. Emanuele N. V., LaPaglia N., Steiner J., Kirsteins L., Emanuele M. A., (2001). Effect of chronic ethanol exposure on female rat reproductive cyclicity and hormone secretion. Alcohol Clin Exp Res 25, 1025-29.
20. Enoch R. R., Stanko J. P., Greiner S. N., Youngblood G. L., Rayner J. L., Fenton S. E., (2007). Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats. Environ Health Perspect 115, 541-47.
21. Fielden M. R., Fong C. J., Haslam S. Z., Zacharewski T. R., (2002). Normal mammary gland morphology in pubertal female mice following in utero and lactational exposure to genistein at levels comparable to human dietary exposure. Toxicol Lett 21, 181-91.
22. Fenton S. E., (2006). Endocrine-disrupting compounds and mammary gland development: Early exposure and later life consequences. Endocrinology 147, S18-24.
23. Fenton S. E., Hamm J. T., Birnbaum L. S., Youngblood G. L., (2002). Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 67, 63-74.
24. Foley J., Dann P., Hong J., Cosgrove J., Dreyer B., Rimm D., Dunbar W. P., Wysolmerski J., (2001). Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. Development 128, 513-25.
25. Frawley L. S., Henricks D. M., (1979). Mode of gonadotropin secretion in infantile female rats and the role of estrogen in feedback regulation. Endocrinology 105, 1064-72.
26. Goyal H. O., Robateau A., Braden T. D., Williams C. S., Srivastava K. K., Ali K., (2003). Neonatal estrogen exposure of male rats alters reproductive functions at adulthood. Biol Reprod 68, 2081-91.
27. Hoover R. N., Hyer M., Pfeiffer R. M., Adam E., Bond B., Cheville A. L., Colton T., Hartge P., Hatch E. E., Herbst A. L., Karlan B. Y., Kaufman R., Noller K. L., Palmer J. R., Robboy S. J., Saal R. C., Strohsnitter W., Titus-Ernstoff L., Troisi R., (2011). Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 365, 1304-14.
28. Hovey R. C., Asai-Sato M., Warri A., Terry-Koroma B., Colyn N., Ginsburg E., Vonderhaar B. K., (2005). Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland. Biol Reprod 72, 423-35.
29. Howard B. A., Gusterson B. A., (2000). Human breast development. J Mammary Gland Biol Neoplasia 5, 119-37.
30. Hvid H., Klopfleisch R., Vienberg S., Hansen B. F., Thorup I., Jensen H. E., Oleksiewicz M. B., (2011). Unique expression pattern of the three insulin receptor family members in the rat mammary gland: Dominance of IGF-1R and IRR over the IR, and cyclical IGF-1R expression. J Appl Toxicol 31, 312-28.
31. IBCERCC (Interagency Breast Cancer and Environmental Research Coordinating Committee). (2013). Breast Cancer and the Environment: Prioritizing Prevention. Accessed June 17, 2016. https://www.niehs.nih.gov/about/boards/ibcercc/.
32. Kao Y. H., Hiipakka R. A., Liao S., (2000). Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141, 980-87.
33. Kariagina A., Aupperlee M. D., Haslam S. Z., (2008). Progesterone receptor isoform functions in normal breast development and breast cancer. Crit Rev Eukaryot Gene Expr 18, 11-33.
34. Kim H. S., Shin J. H., Moon H. J., Kim T. S., Kang I. H., Seok J. H., Kim I. Y., Park K. L., Han S. Y., (2002). Evaluation of the 20-day pubertal female assay in Sprague-Dawley rats treated with DES, tamoxifen, testosterone, and flutamide. Toxicol Sci 67, 52-62.
35. King-Herbert A. P., Sills R. C., Bucher J. R., (2010). Commentary: Update on animal models for NTP studies. Toxicol Pathol 38, 180-81.
36. King-Herbert A. P., Thayer K., (2006). NTP workshop: Animal models for the NTP rodent cancer bioassay: Stocks and strains-Should we switch? Toxicol Pathol 34, 802-05.
37. Lewis B. C., Hudgins S., Lewis A., Schorr K., Sommer R., Peterson R. E., Flaws J. A., Furth P. A., (2001). In utero and lactational treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs mammary gland differentiation but does not block the response to exogenous estrogen in the postpubertal female rat. Toxicol Sci 62, 46-53.
38. Lucas J. N., Rudmann D. G., Credille K. M., Irizarry A. R., Peter A., Snyder P. W., (2007). The rat mammary gland: morphologic changes as an indicator of systemic hormonal perturbations induced by xenobiotics. Toxicol Pathol 35, 199-207.
39. Macon M. B., Fenton S. E., (2013). Endocrine disruptors and the breast: Early life effects and later life disease. J Mammary Gland Biol Neoplasia 18, 43-61.
40. Mandrup K. R., Hass U., Christiansen S., Boberg J., (2012). Perinatal ethinyl oestradiol alters mammary gland development in male and female Wistar rats. Int J Androl 35, 385-96.
41. Manservisi F., Gopalakrishnan K., Tibaldi E., Hysi A., Iezzi M., Lambertini L., Teitelbaum S., Chen J., Belpoggi F., (2014). Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female Sprague-Dawley rats. Reprod Toxicol 54, 110-19.
42. Miousse I. R., Sharma N., Blackburn M., Vantrease J., Gomez-Acevedo H., Hennings L., Shankar K., Cleves M. A., Badger T. M., Ronis M. J., (2013). Feeding soy protein isolate and treatment with estradiol have different effects on mammary gland morphology and gene expression in weanling male and female rats. Physiol Genomics 45, 1072-83.
43. Moral R., Santucci-Pereira J., Wang R., Russo I. H., Lamartiniere C. A., Russo J., (2011). In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: An experimental study in rats. Environ Health 10, 5.
44. NTP (National Toxicology Program). (2011). Specifications for the conduct of studies to evaluate the reproductive and developmental toxicity of chemical, biological and physical agents in laboratory animals for the National Toxicology Program (NTP). NIEHS, Research Triangle Park, NC. Accessed August 16, 2016. http://ntp.niehs.nih.gov/ntp/test-info/finalntp-reprospecsmay2011-508.pdf
45. Ninomiya K., Kawaguchi H., Souda M., Taguchi S., Funato M., Umekita Y., Yoshida H., (2007). Effect of neonatally administered diethylstilbestrol on induction of mammary carcinomas induced by 7,12-Dimethylbenz[a]anthracene in female rats. Toxicol Pathol 35, 813-18.
46. OECD (Organisation for Economic Co-operation and Development). (2008). Endocrine disruption: A guidance Document for Histologic Evaluation of Endocrine and Reproductive Tests, Part 4, OECD Publishing, Paris. Accessed June 17, 2016. http://www.oecd.org/chemicalsafety/testing/40613059.pdf.
47. OECD (Organisation for Economic Co-operation and Development). (2011). Test No. 443: Extended One-Generation Reproductive Toxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris. doi: 10.1787/9789264122550-en.
48. Plante I., Stewart M. K. G., Laird D. W., (2011). Evaluation of Mammary Gland Development and Function in Mouse Models. J Vis Exp 53,. e2828. http://www.jove.com/video/2828/evaluation-of-mammary-gland-development-and-function-in-mouse-models.
49. Rayner J. L., Enoch R. R., Fenton S. E., (2005). Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Toxicol Sci 87, 255-66.
50. Richert M. M., Schwertfeger K. L., Ryder J. W., Anderson S. M., (2000). An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 5, 227-41.
51. Rocca M. S., Pepperl S., (2000). Assessment of pubertal development and thyroid function in juvenile male rats. EPA, Washington, DC.
52. Rudel R. A., Fenton S. E., Ackerman J. M., Euling S. Y., Makris S. L., (2011). Environmental exposures and mammary gland development: State of the science, public health implications, and research recommendations. Environ Health Perspect 119, 1053-61.
53. Rudmann D. G., Cohen I. R., Robbins M. R., Coutant D. E., Henck J. W., (2005). Androgen dependent mammary gland virilism in rats given the selective estrogen receptor modulator LY2066948 hydrochloride. Toxicol Pathol 33, 711-19.
54. Russo J., Tay L. K., Ciocca D. R., Russo I. H., (1983). Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis. Environ Health Perspect 49, 185.
55. Russo J., Russo I. H., (2004). Development of the human breast. Maturitas 49, 2-15.
56. Saji S., Jensen E. V., Nilsson S., Rylander T., Warner M., Gustafsson J. A., (2000). Estrogen receptors alpha and beta in the rodent mammary gland. Proc Natl Acad Sci 97, 337-42.
57. Sandhu R., Chollet-Hinton L., Kirk E. L., Midkiff B., Troester M. A., (2016). Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma. Hum Pathol 48, 60-68.
58. Schwarzman M. R., Ackerman J. M., Dairkee S. H., Fenton S. E., Johnson D., Navarro K. M., Osborne G., Rudel R. A., Solomon G. M., Zeise L., Janssen S., (2015). Screening for chemical contributions to breast cancer risk: A case study for chemical safety evaluation. Environ Health Perspect 123, 1255-64.
59. SEER (Surveillance, Epidemiology, and End Results Program). (2014). SEER Cancer Statistics Review 1975-2011. National Cancer Institute. Accessed June 17, 2016. http://seer.cancer.gov/archive/csr/1975-2011/.
60. Sharpe R. M., Atanassova N., McKinnell C., Parte P., Turner K. J., Fisher J. S., Kerr J. B., Groome N. P., Macpherson S., Millar M. R., Saunders P. T., (1998). Abnormalities in functional development of the Sertoli cells in rats treated neonatally with diethylstilbestrol: a possible role for estrogens in Sertoli cell development. Biol Reprod 59, 1084-94.
61. Stanko J. P., Kissling G. E., Chappell V. A., Fenton S. E., (. in press). Differences in the rate of in situ mammary gland development and other developmental endpoints in three strains of rat commonly used in toxicity testing studies: Implications for timing of mammary carcinogen exposure. Toxicol Pathol.
62. Stoker T. E., Parks L. G., Gray L. E., Cooper R. L., (2000). Endocrine-disrupting chemicals: Prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee. Crit Rev Toxicol 30, 197-252.
63. Tan K. P., Chen J., Ward W. E., Thompson L. U., (2004). Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp Biol Med (Maywood) 229, 147-57.
64. Thordarson G., Jin E., Guzman R. C., Swanson S. M., Nandi S., Talamantes F., (1995). Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis 16, 2847-53.
65. Tucker D. K., Foley J. F., Hayes-Bouknight S. A., Fenton S. E, Preparation of high quality hematoxylin and eosin-stained sections from rodent mammary gland whole mounts for histopathologic review. Toxicol Pathol. Published electronically July 29, 2016. pii: 0192623316660769.
66. Vandenberg L. N., Schaeberle C. M., Rubin B. S., Sonnenschein C., Soto A. M., (2013). The male mammary gland: a target for the xenoestrogen bisphenol A. Reprod Toxicol 37, 15-23.
67. Vorderstrasse B. A., Fenton S. E., Bohn A. A., Cundiff J. A., Lawrence B. P., (2004). A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation. Toxicol Sci 78, 248-57.
68. Ward I. L., Ward O. B., Affuso J. D., Long W. D., French J. A., Hendricks S. E., (2003). Fetal testosterone surge: Specific modulations induced in male rats by maternal stress and/or alcohol consumption. Horm Behav 43, 531-39.
69. Weisz J., Ward I. L., (1980). Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring. Endocrinology 106, 306-16.
70. White S. S., Calafat A. M., Kuklenyik Z., Villanueva L., Zehr R. D., Helfant L., Strynar M. J., Lindstrom A. B., Thibodeaux J. R., Wood C., Fenton S. E., (2007). Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 96, 133-44.
71. White S. S., Stanko J. P., Kato K., Calafat A. M., Hines E. P., Fenton S. E., (2011). Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ Health Perspect 119, 1070-76. doi: 10.1289/ehp.1002741.
72. Wilson M. E., Handa R. J., (1997). Gonadotropin secretion in infantile rats exposed to ethanol in utero. Alcohol 14, 497-501.
73. Zoeller R. T., Brown T. R., Doan L. L., Gore A. C., Skakkebaek N. E., Soto A. M., Woodruff T. J., Vom Saal F. S., (2012). Endocrine-disrupting chemicals and public health protection: A statement of principles from The Endocrine Society. Endocrinology 153, 4097-110.